Excalibur Management Corp bought a new position in Albemarle Co. (NYSE:ALB – Free Report) during the second quarter, Holdings Channel reports. The institutional investor bought 2,598 shares of the specialty chemicals company’s stock, valued at approximately $248,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. WFA Asset Management Corp acquired a new stake in shares of Albemarle during the 1st quarter worth approximately $25,000. First Community Trust NA bought a new position in Albemarle during the 2nd quarter worth $25,000. CVA Family Office LLC increased its position in Albemarle by 610.0% in the second quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 244 shares during the period. Jones Financial Companies Lllp lifted its stake in Albemarle by 2,942.9% in the fourth quarter. Jones Financial Companies Lllp now owns 213 shares of the specialty chemicals company’s stock valued at $31,000 after buying an additional 206 shares during the last quarter. Finally, First Financial Corp IN bought a new stake in Albemarle in the first quarter valued at $32,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ALB has been the topic of a number of analyst reports. Piper Sandler dropped their price objective on shares of Albemarle from $95.00 to $90.00 and set an “underweight” rating on the stock in a report on Thursday, August 8th. Bank of America dropped their price target on shares of Albemarle from $135.00 to $126.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. UBS Group reduced their price objective on Albemarle from $124.00 to $109.00 and set a “neutral” rating for the company in a research report on Tuesday, July 9th. Oppenheimer decreased their price objective on Albemarle from $188.00 to $178.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Finally, JPMorgan Chase & Co. cut their target price on Albemarle from $115.00 to $78.00 and set a “neutral” rating on the stock in a research note on Monday, August 19th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $117.10.
Albemarle Stock Performance
NYSE:ALB opened at $89.35 on Tuesday. The company has a 50-day moving average of $87.53 and a 200-day moving average of $107.71. The firm has a market cap of $10.50 billion, a price-to-earnings ratio of 32.49, a price-to-earnings-growth ratio of 8.03 and a beta of 1.54. The company has a current ratio of 2.67, a quick ratio of 1.75 and a debt-to-equity ratio of 0.38. Albemarle Co. has a twelve month low of $71.97 and a twelve month high of $183.50.
Albemarle (NYSE:ALB – Get Free Report) last issued its earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.49). The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. Albemarle had a positive return on equity of 6.38% and a negative net margin of 6.72%. The company’s quarterly revenue was down 39.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $7.33 earnings per share. Analysts forecast that Albemarle Co. will post 0.69 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, September 13th will be issued a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.81%. This is a boost from Albemarle’s previous quarterly dividend of $0.40. The ex-dividend date is Friday, September 13th. Albemarle’s payout ratio is presently 58.91%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
- Five stocks we like better than Albemarle
- What is the Dow Jones Industrial Average (DJIA)?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Use the MarketBeat Dividend Calculator
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What is a Bond Market Holiday? How to Invest and Trade
- 5 Oversold Stocks to Buy Right Now
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.